If you're seeking alternatives due to cost, availability, or treatment customization, PlexusDx offers compounded GLP-1 medications and dual-compound therapies designed to match your individual metabolic needs
External resources TRAVERSE Trial - New England Journal of Medicine - Landmark cardiovascular safety trial for testosterone therapy in 5,246 men American Urological Association - Testosterone Deficiency Guidelines - Evidence-based clinical guidelines for diagnosing and treating hypogonadism CJC-1295 Clinical Study - PubMed - Prolonged stimulation of growth hormone and IGF-1 by CJC-1295 in healthy adults Endocrine Society - Testosterone Therapy Guidelines - Comprehensive clinical guidance for testosterone prescribing and monitoring FDA Safety Communication on Testosterone Products - Federal safety guidance and labeling requirements for TRT products For those who want to go deeper into peptide science, SeekPeptides maintains a continuously updated library of peptide guides, calculators, and protocol resources
Certain individuals should avoid tirzepatide, including those with past issues such as pancreatitis, a family or personal history of medullary thyroid carcinoma, or severe gastrointestinal problems
"We don't know how effective it's going to be
The agency notes that semaglutide salt forms, including semaglutide sodium and semaglutide acetate, are not equivalent to the active ingredient used in FDA-approved drugs and are not authorized for compounding
There are currently two phase I trials with other monoclonal antibodies against IFN-: IAGS-009 completed phase I (NCT00960362) and JNJ-55920839 is in recruiting phase (NCT02609789)
